George Lazarou, MD
Urogynecology and Reconstructive Pelvic Surgery · Mineola, NYNPI 1801976378
Payments from drug & device makers
Across 14 payments — averaging $84.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$371
- Carbon Medical Technologies, Inc.$300
- Caldera Medical, Inc$159
- Axonics, Inc.$127
- Medtronic$100
- Baxter Healthcare$56
- plus $72 from 2 others
What the payments were for
- Consulting fees$69358%
- Food & beverage$33328%
- Gifts$15913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 2 | $371 |
| Carbon Medical Technologies, Inc. | 1 | $300 |
| Caldera Medical, Inc | 2 | $159 |
| Axonics, Inc. | 1 | $127 |
| Medtronic | 3 | $100 |
| Baxter Healthcare | 3 | $56 |
| Hologic Sales And Service, LLC | 1 | $43 |
| Lilly USA, LLC | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,186 in reported general payments places this provider in the 25th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.
See all urogynecology and reconstructive pelvic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 127 | $85,763 |
| GemtesaVibegron | 58 | $31,345 |
| Mirabegron ErMirabegron | 14 | $7,143 |
| Solifenacin Succinate | 121 | $6,187 |
| Estradiol | 71 | $4,249 |
| Methenamine Hippurate | 75 | $3,257 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 364 | $2,499 |
| Oxybutynin Chloride ErOxybutynin Chloride | 42 | $1,023 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $769 |
| Trospium Chloride | 15 | $434 |
| Terconazole | 12 | $295 |
| Ciprofloxacin Hcl | 19 | $71 |
| Cephalexin | 15 | $56 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $35 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Mineola
- Bogdan GrigorescuMineola$7K
- Jason KimStony Brook$539K
- Robert LobelAlbany$454K
- Doreen ChungNew Hyde Park$196K
- Helai HeshamNew York$156K
- Harvey WinklerGreat Neck$126K
- Nitya AbrahamBronx$125K
- Robert MoldwinNew Hyde Park$124K
- Dara ShalomGreat Neck$94K
- Melissa LaudanoNew York$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.